vs
Cooper-Standard Holdings Inc.（CPS）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Cooper-Standard Holdings Inc.的季度营收约是Royalty Pharma plc的1.1倍（$672.4M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 0.5%，领先33.9%），Royalty Pharma plc同比增速更快（4.8% vs 1.8%）
库博标准控股是全球领先的汽车零部件供应商，总部位于美国密歇根州诺维。公司主营产品包括橡塑密封件、燃油管、制动管、流体输送软管以及减震系统，目前在全球20个国家开展业务，拥有约3.2万名员工。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CPS vs RPRX — 直观对比
营收规模更大
CPS
是对方的1.1倍
$622.0M
营收增速更快
RPRX
高出3.0%
1.8%
净利率更高
RPRX
高出33.9%
0.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $672.4M | $622.0M |
| 净利润 | $3.3M | $214.2M |
| 毛利率 | 10.4% | — |
| 营业利润率 | 0.1% | 62.4% |
| 净利率 | 0.5% | 34.4% |
| 营收同比 | 1.8% | 4.8% |
| 净利润同比 | -91.7% | 2.9% |
| 每股收益（稀释后） | $0.19 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPSRPRX
| Q4 25 | $672.4M | $622.0M | ||
| Q3 25 | $695.5M | $609.3M | ||
| Q2 25 | $706.0M | $578.7M | ||
| Q1 25 | $667.1M | $568.2M | ||
| Q4 24 | $660.8M | $593.6M | ||
| Q3 24 | — | $564.7M | ||
| Q2 24 | — | $537.3M | ||
| Q1 24 | $0 | $568.0M |
净利润CPSRPRX
| Q4 25 | $3.3M | $214.2M | ||
| Q3 25 | $-7.6M | $288.2M | ||
| Q2 25 | $-1.4M | $30.2M | ||
| Q1 25 | $1.6M | $238.3M | ||
| Q4 24 | $40.2M | $208.2M | ||
| Q3 24 | — | $544.0M | ||
| Q2 24 | — | $102.0M | ||
| Q1 24 | $-31.7M | $4.8M |
毛利率CPSRPRX
| Q4 25 | 10.4% | — | ||
| Q3 25 | 12.5% | — | ||
| Q2 25 | 13.2% | — | ||
| Q1 25 | 11.6% | — | ||
| Q4 24 | 12.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率CPSRPRX
| Q4 25 | 0.1% | 62.4% | ||
| Q3 25 | 3.8% | 70.1% | ||
| Q2 25 | 5.3% | 36.3% | ||
| Q1 25 | 3.3% | 94.0% | ||
| Q4 24 | 4.8% | 60.9% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 50.2% | ||
| Q1 24 | — | -13.0% |
净利率CPSRPRX
| Q4 25 | 0.5% | 34.4% | ||
| Q3 25 | -1.1% | 47.3% | ||
| Q2 25 | -0.2% | 5.2% | ||
| Q1 25 | 0.2% | 41.9% | ||
| Q4 24 | 6.1% | 35.1% | ||
| Q3 24 | — | 96.3% | ||
| Q2 24 | — | 19.0% | ||
| Q1 24 | — | 0.8% |
每股收益（稀释后）CPSRPRX
| Q4 25 | $0.19 | $0.49 | ||
| Q3 25 | $-0.43 | $0.67 | ||
| Q2 25 | $-0.08 | $0.07 | ||
| Q1 25 | $0.09 | $0.55 | ||
| Q4 24 | $2.30 | $0.46 | ||
| Q3 24 | — | $1.21 | ||
| Q2 24 | — | $0.23 | ||
| Q1 24 | $-1.81 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $191.7M | $618.7M |
| 总债务越低越好 | $1.0B | $9.0B |
| 股东权益账面价值 | $-83.5M | $9.7B |
| 总资产 | $1.8B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CPSRPRX
| Q4 25 | $191.7M | $618.7M | ||
| Q3 25 | $147.6M | $938.9M | ||
| Q2 25 | $121.6M | $631.9M | ||
| Q1 25 | $140.4M | $1.1B | ||
| Q4 24 | $170.0M | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | $114.2M | $843.0M |
总债务CPSRPRX
| Q4 25 | $1.0B | $9.0B | ||
| Q3 25 | $1.1B | $8.9B | ||
| Q2 25 | $1.1B | $8.0B | ||
| Q1 25 | $1.1B | $7.6B | ||
| Q4 24 | $1.1B | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | $1.1B | $6.1B |
股东权益CPSRPRX
| Q4 25 | $-83.5M | $9.7B | ||
| Q3 25 | $-102.3M | $9.6B | ||
| Q2 25 | $-97.6M | $9.5B | ||
| Q1 25 | $-114.7M | $9.8B | ||
| Q4 24 | $-125.8M | $10.3B | ||
| Q3 24 | — | $10.3B | ||
| Q2 24 | — | $9.8B | ||
| Q1 24 | $-115.8M | $9.9B |
总资产CPSRPRX
| Q4 25 | $1.8B | $19.6B | ||
| Q3 25 | $1.9B | $19.3B | ||
| Q2 25 | $1.8B | $18.3B | ||
| Q1 25 | $1.8B | $17.6B | ||
| Q4 24 | $1.7B | $18.2B | ||
| Q3 24 | — | $18.0B | ||
| Q2 24 | — | $17.7B | ||
| Q1 24 | $1.8B | $16.1B |
负债/权益比CPSRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $56.2M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $44.6M | — |
| 自由现金流率自由现金流/营收 | 6.6% | — |
| 资本支出强度资本支出/营收 | 1.7% | — |
| 现金转化率经营现金流/净利润 | 16.90× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $16.3M | — |
8季度趋势，按日历期对齐
经营现金流CPSRPRX
| Q4 25 | $56.2M | $827.1M | ||
| Q3 25 | $38.6M | $702.6M | ||
| Q2 25 | $-15.6M | $364.0M | ||
| Q1 25 | $-14.9M | $596.1M | ||
| Q4 24 | $74.7M | $742.5M | ||
| Q3 24 | — | $703.6M | ||
| Q2 24 | — | $658.2M | ||
| Q1 24 | $-14.2M | $664.6M |
自由现金流CPSRPRX
| Q4 25 | $44.6M | — | ||
| Q3 25 | $27.4M | — | ||
| Q2 25 | $-23.4M | — | ||
| Q1 25 | $-32.4M | — | ||
| Q4 24 | $63.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-31.0M | — |
自由现金流率CPSRPRX
| Q4 25 | 6.6% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | -3.3% | — | ||
| Q1 25 | -4.9% | — | ||
| Q4 24 | 9.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度CPSRPRX
| Q4 25 | 1.7% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 2.6% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率CPSRPRX
| Q4 25 | 16.90× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | -9.57× | 2.50× | ||
| Q4 24 | 1.86× | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPS
| Sealing Systems | $357.8M | 53% |
| Fluid Handling Systems | $297.1M | 44% |
| Corporate And Other Segment | $17.4M | 3% |
| Commercial | $6.6M | 1% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
